Small-cap stock below ₹100: Balaxi Pharma share price jumps 10% after Q4 results 2025

Balaxi Pharmaceuticals' shares surged 14.5% on June 2 despite reporting a net loss of ₹117.85 lakh for Q4 FY25. The company's total income declined 37.9% year-on-year. For FY25, it reported a slight profit of ₹360.13 lakh, with revenue down 5.6% from the previous year.

Markets